vs

Side-by-side financial comparison of CABOT CORP (CBT) and Realty Income (O). Click either name above to swap in a different company.

Realty Income is the larger business by last-quarter revenue ($1.5B vs $849.0M, roughly 1.8× CABOT CORP). Realty Income runs the higher net margin — 19.9% vs 8.6%, a 11.3% gap on every dollar of revenue. On growth, Realty Income posted the faster year-over-year revenue change (11.0% vs -11.1%). Realty Income produced more free cash flow last quarter ($1.2B vs $57.0M). Over the past eight quarters, Realty Income's revenue compounded faster (8.6% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Realty Income Corporation is a real estate investment trust that invests in free-standing, single-tenant commercial properties in the United States, the United Kingdom, and six other countries in Europe. These properties are subject to NNN Leases. The company is organized in Maryland with its headquarters in San Diego, California.

CBT vs O — Head-to-Head

Bigger by revenue
O
O
1.8× larger
O
$1.5B
$849.0M
CBT
Growing faster (revenue YoY)
O
O
+22.1% gap
O
11.0%
-11.1%
CBT
Higher net margin
O
O
11.3% more per $
O
19.9%
8.6%
CBT
More free cash flow
O
O
$1.1B more FCF
O
$1.2B
$57.0M
CBT
Faster 2-yr revenue CAGR
O
O
Annualised
O
8.6%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
O
O
Revenue
$849.0M
$1.5B
Net Profit
$73.0M
$296.1M
Gross Margin
24.9%
Operating Margin
15.2%
21.7%
Net Margin
8.6%
19.9%
Revenue YoY
-11.1%
11.0%
Net Profit YoY
-21.5%
48.3%
EPS (diluted)
$1.37
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
O
O
Q4 25
$849.0M
$1.5B
Q3 25
$899.0M
$1.5B
Q2 25
$923.0M
$1.4B
Q1 25
$936.0M
$1.4B
Q4 24
$955.0M
$1.3B
Q3 24
$1.0B
$1.3B
Q2 24
$1.0B
$1.3B
Q1 24
$1.0B
$1.3B
Net Profit
CBT
CBT
O
O
Q4 25
$73.0M
$296.1M
Q3 25
$43.0M
$315.8M
Q2 25
$101.0M
$196.9M
Q1 25
$94.0M
$249.8M
Q4 24
$93.0M
$199.6M
Q3 24
$137.0M
$269.5M
Q2 24
$109.0M
$259.4M
Q1 24
$84.0M
$132.3M
Gross Margin
CBT
CBT
O
O
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
O
O
Q4 25
15.2%
21.7%
Q3 25
15.2%
23.2%
Q2 25
18.1%
15.8%
Q1 25
17.3%
19.3%
Q4 24
16.2%
16.5%
Q3 24
15.0%
21.5%
Q2 24
16.9%
20.7%
Q1 24
15.3%
11.9%
Net Margin
CBT
CBT
O
O
Q4 25
8.6%
19.9%
Q3 25
4.8%
21.5%
Q2 25
10.9%
14.0%
Q1 25
10.0%
18.1%
Q4 24
9.7%
14.9%
Q3 24
13.7%
20.2%
Q2 24
10.7%
19.4%
Q1 24
8.2%
10.5%
EPS (diluted)
CBT
CBT
O
O
Q4 25
$1.37
$0.32
Q3 25
$0.80
$0.35
Q2 25
$1.86
$0.22
Q1 25
$1.69
$0.28
Q4 24
$1.67
$0.23
Q3 24
$2.41
$0.30
Q2 24
$1.94
$0.29
Q1 24
$1.49
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
O
O
Cash + ST InvestmentsLiquidity on hand
$230.0M
$434.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$39.4B
Total Assets
$3.8B
$72.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
O
O
Q4 25
$230.0M
$434.8M
Q3 25
$258.0M
$417.2M
Q2 25
$239.0M
$800.4M
Q1 25
$213.0M
$319.0M
Q4 24
$183.0M
$445.0M
Q3 24
$223.0M
$397.0M
Q2 24
$197.0M
$442.8M
Q1 24
$206.0M
$680.2M
Total Debt
CBT
CBT
O
O
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
O
O
Q4 25
$1.6B
$39.4B
Q3 25
$1.6B
$39.1B
Q2 25
$1.5B
$39.2B
Q1 25
$1.4B
$39.0B
Q4 24
$1.4B
$38.8B
Q3 24
$1.4B
$38.5B
Q2 24
$1.3B
$38.6B
Q1 24
$1.4B
$39.0B
Total Assets
CBT
CBT
O
O
Q4 25
$3.8B
$72.8B
Q3 25
$3.8B
$71.3B
Q2 25
$3.8B
$71.4B
Q1 25
$3.8B
$69.8B
Q4 24
$3.6B
$68.8B
Q3 24
$3.7B
$68.5B
Q2 24
$3.6B
$68.1B
Q1 24
$3.6B
$68.3B
Debt / Equity
CBT
CBT
O
O
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
O
O
Operating Cash FlowLast quarter
$126.0M
$1.2B
Free Cash FlowOCF − Capex
$57.0M
$1.2B
FCF MarginFCF / Revenue
6.7%
77.6%
Capex IntensityCapex / Revenue
8.1%
3.3%
Cash ConversionOCF / Net Profit
1.73×
4.06×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$3.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
O
O
Q4 25
$126.0M
$1.2B
Q3 25
$219.0M
$943.1M
Q2 25
$249.0M
$1.1B
Q1 25
$73.0M
$787.5M
Q4 24
$124.0M
$972.0M
Q3 24
$204.0M
$841.5M
Q2 24
$207.0M
$981.2M
Q1 24
$176.0M
$778.7M
Free Cash Flow
CBT
CBT
O
O
Q4 25
$57.0M
$1.2B
Q3 25
$155.0M
$909.9M
Q2 25
$188.0M
$1.0B
Q1 25
$1.0M
$764.6M
Q4 24
$47.0M
$935.8M
Q3 24
$112.0M
$807.9M
Q2 24
$155.0M
$939.2M
Q1 24
$133.0M
$769.0M
FCF Margin
CBT
CBT
O
O
Q4 25
6.7%
77.6%
Q3 25
17.2%
61.9%
Q2 25
20.4%
73.3%
Q1 25
0.1%
55.4%
Q4 24
4.9%
69.8%
Q3 24
11.2%
60.7%
Q2 24
15.3%
70.1%
Q1 24
13.1%
61.0%
Capex Intensity
CBT
CBT
O
O
Q4 25
8.1%
3.3%
Q3 25
7.1%
2.3%
Q2 25
6.6%
1.9%
Q1 25
7.7%
1.7%
Q4 24
8.1%
2.7%
Q3 24
9.2%
2.5%
Q2 24
5.1%
3.1%
Q1 24
4.2%
0.8%
Cash Conversion
CBT
CBT
O
O
Q4 25
1.73×
4.06×
Q3 25
5.09×
2.99×
Q2 25
2.47×
5.39×
Q1 25
0.78×
3.15×
Q4 24
1.33×
4.87×
Q3 24
1.49×
3.12×
Q2 24
1.90×
3.78×
Q1 24
2.10×
5.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

O
O

Product And Service Retail$900.8M61%
Other$531.5M36%

Related Comparisons